Tilray Brands Inc.
Tilray Brands Executes Debt-for-Equity Exchange Transaction
Summary
On May 13, 2024, Tilray Brands, Inc. entered into a private debt-for-equity exchange transaction with an unrelated party. The Company issued up to 13.1 million shares of its common stock in exchange for $19.8 million aggregate principal amount of its 2024 Convertible Notes. The shares were issued without registration under the Securities Act of 1933, in reliance on the exemption provided by Section 3(a)(9) of the Securities Act. After the transaction, $330,000 in principal amount of the 2024 Convertible Notes remain outstanding.
Profitelligence Alerts
Get alerts for TLRY
Be first to know when Tilray Brands Inc. files with the SEC.
Filing Categories
Advertisement
About Tilray Brands Inc.
Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.
Official SEC Documents
Advertisement